Eagle Veterinary Technology (044960) stock price, revenue, and financials
Eagle Veterinary Technology annual revenue was ₩40.36 b in FY 2020
₩40.4 B
Eagle Veterinary Technology Revenue FY, 2020Eagle Veterinary Technology Gross profit (FY, 2020)15.3 B
Eagle Veterinary Technology Net income (FY, 2020)2.5 B
Eagle Veterinary Technology EBITDA (FY, 2020)5.8 B
Eagle Veterinary Technology EBIT (FY, 2020)3.5 B
Eagle Veterinary Technology Cash, 31-Dec-20205.3 B
Eagle Veterinary Technology Revenue Breakdown
Eagle Veterinary Technology revenue breakdown by business segment: 100.0% from LIVESTOCK FIELD
Eagle Veterinary Technology revenue breakdown by geographic segment: 100.0% from SOUTH KOREA
Eagle Veterinary Technology Income Statement
Annual
| KRW | FY, 2018 | FY, 2019 | FY, 2020 |
|---|---|---|---|
Revenue | 30.3b | 34.4b | 40.4b |
Cost of goods sold | (18.9b) | (22.2b) | (25.3b) |
Gross profit | 11.5b | 12.4b | 15.3b |
R&D expense | (197.0m) | (163.5m) | (128.8m) |
Operating expense total | (8.4b) | (8.1b) | (9.6b) |
Depreciation and amortization | (1.8b) | (2.1b) | (2.0b) |
EBITDA | 3.1b | 4.2b | 5.8b |
EBIT | 885.7m | 1.4b | 3.5b |
Interest expense | (415.3m) | (240.1m) | (179.2m) |
Interest income | 89.8m | 97.7m | 79.9m |
Pre tax profit | 1.1b | 1.3b | 2.9b |
Income tax expense | (62.9m) | (31.8m) | (470.5m) |
Net Income | 1.0b | 1.2b | 2.5b |
Quarterly
| KRW | Q1, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
|---|---|---|---|---|
Revenue | 8.1b | 9.5b | 10.6b | 10.2b |
Cost of goods sold | (5.2b) | (6.1b) | (6.7b) | (6.2b) |
Gross profit | 3.0b | 3.4b | 3.9b | 4.0b |
R&D expense | (10.0m) | (13.0m) | (30.4m) | (40.2m) |
Operating expense total | (1.8b) | (2.3b) | (2.5b) | (2.5b) |
Depreciation and amortization | (525.2m) | (545.0m) | (545.5m) | (461.8m) |
EBITDA | 1.2b | 1.1b | 1.3b | 1.5b |
EBIT | 571.3m | 587.0m | 723.9m | 890.4m |
Interest expense | (60.1m) | (48.6m) | (45.1m) | (179.9m) |
Interest income | 25.8m | 33.8m | 22.9m | 21.8m |
Pre tax profit | 554.6m | 847.9m | 558.1m | 593.5m |
Income tax expense | (82.3m) | (119.1m) | (65.2m) | (67.9m) |
Net Income | 472.3m | 728.8m | 492.9m | 525.6m |
Eagle Veterinary Technology Balance Sheet
Annual
| KRW | FY, 2018 | FY, 2019 | FY, 2020 |
|---|---|---|---|
Cash | 449.0m | 1.7b | 5.3b |
Accounts Receivable | 5.5b | 6.7b | 7.9b |
Prepaid Expenses | 395.5m | 279.7m | 843.3m |
Inventories | 11.2b | 10.2b | 7.6b |
Current Assets | 19.6b | 21.4b | 23.2b |
PP&E | 24.2b | 22.9b | 19.7b |
Total Assets | 46.1b | 45.9b | 48.4b |
Accounts Payable | 1.8b | 1.1b | 1.6b |
Short-term debt | 4.2b | 3.2b | 2.2b |
Current Liabilities | 8.0b | 6.6b | 6.5b |
Long-term debt | 3.5b | 3.8b | 4.2b |
Non-Current Liabilities | 3.6b | 3.8b | 4.2b |
Total Debt | 7.7b | 6.9b | 6.5b |
Total Liabilities | 11.6b | 10.4b | 10.7b |
Common Stock | 6.3b | 6.3b | 6.3b |
Additional Paid-in Capital | 19.0b | 19.0b | 19.0b |
Retained Earnings | 10.0b | 10.9b | 13.1b |
Total Equity | 34.5b | 35.5b | 37.7b |
Quarterly
| KRW | Q1, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
|---|---|---|---|---|
Cash | 601.4m | 3.1b | 3.6b | 3.2b |
Accounts Receivable | 6.1b | 7.6b | 7.6b | 8.1b |
Prepaid Expenses | 618.5m | 979.2m | 936.3m | 669.6m |
Inventories | 12.7b | 9.2b | 9.2b | 9.3b |
Current Assets | 22.2b | 23.8b | 23.7b | 22.8b |
PP&E | 24.1b | 22.5b | 22.5b | 22.5b |
Total Assets | 48.6b | 47.9b | 47.9b | 48.1b |
Accounts Payable | 3.1b | 2.5b | 2.6b | 2.1b |
Short-term debt | 5.1b | 3.2b | 3.4b | 3.3b |
Current Liabilities | 10.3b | 8.1b | 8.1b | 7.7b |
Long-term debt | 3.5b | 3.7b | 3.3b | 3.3b |
Non-Current Liabilities | 3.5b | 3.8b | 3.3b | 3.3b |
Total Debt | 8.6b | 6.9b | 6.6b | 6.5b |
Total Liabilities | 13.8b | 11.9b | 11.4b | 11.0b |
Common Stock | 6.3b | 6.3b | 6.3b | 6.3b |
Additional Paid-in Capital | 19.0b | 19.0b | 19.0b | 19.0b |
Retained Earnings | 10.2b | 11.4b | 11.9b | 12.4b |
Total Equity | 34.8b | 36.0b | 36.5b | 37.0b |
Eagle Veterinary Technology Cash Flow
Annual
| KRW | FY, 2018 | FY, 2019 | FY, 2020 |
|---|---|---|---|
Net Income | 1.0b | 1.2b | 2.5b |
Depreciation and Amortization | 1.8b | 2.1b | 2.0b |
Accounts Receivable | 289.4m | (1.2b) | (2.2b) |
Inventories | 134.8m | 1.2b | 2.5b |
Accounts Payable | (822.2m) | (664.5m) | 439.6m |
Cash From Operating Activities | 1.8b | 2.7b | 5.9b |
Cash From Investing Activities | 1.1b | (240.1m) | (876.0m) |
Short-term Borrowings | (3.4b) | (870.6m) | (120.0m) |
Long-term Borrowings | (1.5b) | (340.2m) | (674.5m) |
Dividends Paid | (245.5m) | ||
Cash From Financing Activities | (3.2b) | (1.2b) | (1.4b) |
Net Change in Cash | (302.3m) | 1.2b | 3.6b |
Quarterly
| KRW | Q1, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
|---|---|---|---|---|
Net Income | 472.3m | 728.8m | 1.2b | 1.7b |
Depreciation and Amortization | 525.2m | 545.0m | 1.1b | 1.6b |
Accounts Receivable | (375.4m) | (713.3m) | (1.5b) | (2.2b) |
Inventories | (1.4b) | 982.3m | 992.0m | 864.6m |
Accounts Payable | 1.3b | 1.4b | 1.4b | 944.7m |
Cash From Operating Activities | 99.1m | 1.8b | 2.6b | 3.1b |
Cash From Investing Activities | (592.3m) | (252.2m) | 154.9m | (537.1m) |
Short-term Borrowings | 696.6m | (120.0m) | ||
Long-term Borrowings | (53.1m) | (81.1m) | (839.9m) | (937.3m) |
Cash From Financing Activities | 643.5m | (81.1m) | (839.9m) | (1.1b) |
Net Change in Cash | 152.5m | 1.5b | 2.0b | 1.5b |
Eagle Veterinary Technology Ratios
| KRW | FY, 2018 |
|---|
